Analysts think ATOS stock price could increase by 1491%
Feb 07, 2026, 12:25 PM
-14.37%
What does ATOS do
Atossa Therapeutics, based in Seattle, focuses on developing oral (Z)-endoxifen for breast cancer treatment and prevention, having completed four Phase I and two Phase II clinical studies. The company went public on November 8, 2012, and employs 10 people.
6 analysts think ATOS stock price will increase by 1490.74%. The current median analyst target is $84.15 compared to a current stock price of $5.29. The lowest analysts target is $60.60 and the highest analyst target is $126.00.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.